Griseofulvin Tablet
Product Images NDC 0781-5515

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Griseofulvin (NDC 0781-5515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of Griseofulvin showing its molecular formula C17H17ClO6 and molecular weight 352.77. The diagram depicts the arrangement of atoms including chlorine, oxygen, carbon, and hydrogen in the compound.*

FDA Label Image

250 mg (Image 02)

Griseofulvin Tablets USP (microsize) 250 mg oral tablets label by Sandoz Inc. The label indicates a package size of 100 tablets. It includes storage instructions, dosage guidance, and safety warnings, with a barcode and manufacturer information. The NDC is 0781-5514-01.*

FDA Label Image

500 mg (Image 03)

Label for Griseofulvin Tablets USP (microsize) 500 mg oral tablets by Sandoz Inc. The label indicates 100 tablets in the container, Rx only status, and includes storage instructions (20° to 25°C). It also contains dosage information and warnings about keeping the drug out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.